Imitrex (Sumatriptan)

Sumatriptan works by selectively stimulating serotonin 5‑HT1B and 5‑HT1D receptors in the brain. This causes constriction of dilated cranial blood vessels and blocks the release of inflammatory neuropeptides, which together reduce migraine pain and associated symptoms.

The appropriate dose of Imitrex is determined by a qualified prescriber based on the patient’s medical condition and response to therapy. Patients should follow the specific dosing instructions provided by their healthcare professional.

Safety of Imitrex in pregnancy or while breastfeeding has not been fully established. It should only be used if the potential benefit justifies any possible risk to the fetus or infant, and this decision must be made by a healthcare provider.

To order Imitrex, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and necessary import documentation.

Imitrex belongs to the triptan class, which directly targets serotonin receptors to abort migraine attacks. Compared with non‑specific analgesics, triptans like sumatriptan provide faster and more specific migraine relief, but they are contraindicated in certain cardiovascular conditions.

Imitrex should be stored at room temperature, below 25 °C. Keep the nasal spray in its original container, protect it from moisture and direct sunlight, and ensure the cap is tightly closed when not in use.

Imitrex is administered as a single intranasal spray into one nostril at the onset of a migraine. The patient should tilt the head slightly forward, insert the nozzle, and press the actuator to deliver the dose as instructed by the prescriber.

Serious risks include coronary vasospasm, myocardial infarction, severe hypertension, and serotonin syndrome, especially when combined with other serotonergic drugs. Patients should seek immediate medical attention if they experience chest pain, severe headache, or signs of an allergic reaction.

Imitrex should not be used by individuals with known coronary artery disease, uncontrolled hypertension, a history of myocardial infarction, hemiplegic or basilar migraine, or those taking MAO inhibitors within the past 14 days. Consultation with a healthcare professional is essential before starting therapy.